-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical News, March 29, Chinese patent medicinal plaster is a traditional method of external administration in my country, and it has always been favored by the public, and pharmacies are the main channel for its sales.
According to data from Menet.
com, the market for proprietary Chinese medicine plasters in physical pharmacies in key cities has grown steadily in recent years.
In 2020, affected by the epidemic, sales are expected to decline year-on-year.
From the perspective of urban structure, Shenzhen, Shanghai, and Guangzhou rank among the top three in terms of sales.
The total market share of TOP20 products exceeds 80%.
Among them, 11 are exclusive products, involving Tibet Qizheng Tibetan Medicine, Yunnan Baiyao Group Wuxi Pharmaceutical, Henan Lingrui Pharmaceutical, Yabao Pharmaceutical Group, Jiangsu Kangyuan Sunshine Pharmaceutical Industry and other enterprises.
In terms of brand TOP20, Tibet Qizheng Tibetan Medicine's Xiaotong Plaster, Yunnan Baiyao Wuxi Pharmaceutical's Yunnan Baiyao Gao, Anke Yuliangqing Pharmaceutical's Huoxue Zhitong Gao ranked in the top three; in terms of the number of brands, Henan Lingrui The number of pharmaceuticals is the most, there are five.
According to data from Menet.
com, the market for proprietary Chinese medicine plasters in physical pharmacies in key cities has grown steadily in recent years.
In 2020, affected by the epidemic, sales are expected to decline year-on-year.
From the perspective of urban structure, Shenzhen, Shanghai, and Guangzhou rank among the top three in terms of sales.
The total market share of TOP20 products exceeds 80%.
Among them, 11 are exclusive products, involving Tibet Qizheng Tibetan Medicine, Yunnan Baiyao Group Wuxi Pharmaceutical, Henan Lingrui Pharmaceutical, Yabao Pharmaceutical Group, Jiangsu Kangyuan Sunshine Pharmaceutical Industry and other enterprises.
In terms of brand TOP20, Tibet Qizheng Tibetan Medicine's Xiaotong Plaster, Yunnan Baiyao Wuxi Pharmaceutical's Yunnan Baiyao Gao, Anke Yuliangqing Pharmaceutical's Huoxue Zhitong Gao ranked in the top three; in terms of the number of brands, Henan Lingrui The number of pharmaceuticals is the most, there are five.
Chinese patent medicinal plasters "Shenzhen, Shanghai and Guangzhou" are selling well! Qizheng, Lingrui.
.
.
11 exclusive products "Baping"
.
.
11 exclusive products "Baping"
2020E city layout of proprietary Chinese medicine plasters in physical pharmacies in key cities (unit: ten thousand yuan)
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
According to data from Menet.
com, the market for proprietary Chinese medicine plasters in physical pharmacies in key cities has grown steadily in recent years.
In 2020, affected by the epidemic, sales are expected to decline year-on-year.
From the perspective of the urban structure, Shenzhen, Shanghai, and Guangzhou rank among the top three in terms of sales.
Among them, Shenzhen is the only city with a sales volume of over 300 million yuan, followed by Shanghai.
In addition, Guangzhou, Tianjin, Hangzhou and other cities have sales of more than 100 million yuan.
com, the market for proprietary Chinese medicine plasters in physical pharmacies in key cities has grown steadily in recent years.
In 2020, affected by the epidemic, sales are expected to decline year-on-year.
From the perspective of the urban structure, Shenzhen, Shanghai, and Guangzhou rank among the top three in terms of sales.
Among them, Shenzhen is the only city with a sales volume of over 300 million yuan, followed by Shanghai.
In addition, Guangzhou, Tianjin, Hangzhou and other cities have sales of more than 100 million yuan.
2020E Key City Entity Pharmacy TCM Plaster Products TOP20
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Note: * is an exclusive product
The total market share of TOP20 products accounted for more than 80%, and the market concentration was high.
There were 9 products with sales exceeding 100 million yuan.
The number of orthopedic analgesics was the largest, with 10, followed by six traumatic injuries.
Among them, Xiaotong Plaster is firmly in the "sales crown" throne, with a market share of more than 15%; Yunnan Baiyao Ointment ranks second with 10.
23%.
In addition, among the TOP20 products, there are 11 exclusive products, involving Tibet Qizheng Tibetan Medicine, Yunnan Baiyao Group Wuxi Pharmaceutical, Henan Lingrui Pharmaceutical, Yabao Pharmaceutical Group, Sinopharm Dezhong (Foshan) Pharmaceutical, Jiangsu Kangyuan Sunshine Pharmaceutical and other companies.
There were 9 products with sales exceeding 100 million yuan.
The number of orthopedic analgesics was the largest, with 10, followed by six traumatic injuries.
Among them, Xiaotong Plaster is firmly in the "sales crown" throne, with a market share of more than 15%; Yunnan Baiyao Ointment ranks second with 10.
23%.
In addition, among the TOP20 products, there are 11 exclusive products, involving Tibet Qizheng Tibetan Medicine, Yunnan Baiyao Group Wuxi Pharmaceutical, Henan Lingrui Pharmaceutical, Yabao Pharmaceutical Group, Sinopharm Dezhong (Foshan) Pharmaceutical, Jiangsu Kangyuan Sunshine Pharmaceutical and other companies.
2020E Key City Entity Pharmacy TCM Plaster Brand TOP20
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
In terms of brand TOP20, Tibet Qizheng Tibetan Medicine's Xiaotong Plaster, Yunnan Baiyao Wuxi Pharmaceutical's Yunnan Baiyao Cream, Anke Yuliangqing Pharmaceutical's Huoxuezhitong Ointment ranked in the top three, Henan Lingrui Pharmaceutical's Tongluo Qupain Five products including Zhuanggushexiang Pain Relief Cream and Joint Pain Relief Cream are among the TOP20 brands.
Xiaotong Plaster is firmly in the top of the market, and Lingrui's five major brands are eye-catching
Market share of Xiaotong plaster in physical pharmacies in key cities in recent years
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Xiaotong Plaster is used for acute and chronic sprains, bruises and bruises, bone hyperplasia, rheumatism and rheumatoid pain, frozen shoulder, etc.
It is the exclusive product of Tibet Qizheng Tibetan Medicine.
According to data from Meinnet.
com, the sales of physical medicine Xiaotong plasters in key cities have exceeded 300 million yuan in recent years, ranking first in the market share of proprietary Chinese medicine plasters for many years.
At the end of December 2020, Qizheng Tibetan Medicine issued an announcement stating that its two exclusive products, Honghua Ruyi Pills and Ruyi Zhenbao Tablets, were included in the "National Medical Insurance Catalog (2020)" for the first time, which will expand the market network and upgrade the two products.
The sales scale plays a positive role in promoting and has a positive impact on the company's long-term business development.
In addition, the company has 17 varieties including Xiaotong Plaster, Baimai Ointment, Qingpeng Ointment, Renqing Mangjue Capsule, etc.
, which have been included in the "National Medical Insurance Catalogue (2020)".
It is the exclusive product of Tibet Qizheng Tibetan Medicine.
According to data from Meinnet.
com, the sales of physical medicine Xiaotong plasters in key cities have exceeded 300 million yuan in recent years, ranking first in the market share of proprietary Chinese medicine plasters for many years.
At the end of December 2020, Qizheng Tibetan Medicine issued an announcement stating that its two exclusive products, Honghua Ruyi Pills and Ruyi Zhenbao Tablets, were included in the "National Medical Insurance Catalog (2020)" for the first time, which will expand the market network and upgrade the two products.
The sales scale plays a positive role in promoting and has a positive impact on the company's long-term business development.
In addition, the company has 17 varieties including Xiaotong Plaster, Baimai Ointment, Qingpeng Ointment, Renqing Mangjue Capsule, etc.
, which have been included in the "National Medical Insurance Catalogue (2020)".
In February of this year, Qizheng Tibetan Medicine disclosed its 2020 performance report, with revenue of 1.
476 billion yuan, an increase of 5.
24% year-on-year, of which the pharmaceutical business increased by 4.
55% year-on-year; net profit was 406 million yuan, an increase of 11.
39% year-on-year, with steady growth in performance.
Recently, Qizheng Tibetan Medicine announced its participation in the establishment of an equity investment fund.
The company signed an agreement with Guangyao Jinshen and Guangyao Baiyunshan to jointly establish Guangzhou Guangyao Jinzang Equity Investment Partnership (Limited Partnership) with a total scale of 115 million Yuan, the company as a limited partner subscribed to contribute 67.
85 million yuan (accounting for 59%).
The fund specifically invested in Guangzhou Baiyunshan Yixintang Pharmaceutical Investment Development Co.
, Ltd.
for the development of the pharmaceutical retail enterprise Baiyuantang.
476 billion yuan, an increase of 5.
24% year-on-year, of which the pharmaceutical business increased by 4.
55% year-on-year; net profit was 406 million yuan, an increase of 11.
39% year-on-year, with steady growth in performance.
Recently, Qizheng Tibetan Medicine announced its participation in the establishment of an equity investment fund.
The company signed an agreement with Guangyao Jinshen and Guangyao Baiyunshan to jointly establish Guangzhou Guangyao Jinzang Equity Investment Partnership (Limited Partnership) with a total scale of 115 million Yuan, the company as a limited partner subscribed to contribute 67.
85 million yuan (accounting for 59%).
The fund specifically invested in Guangzhou Baiyunshan Yixintang Pharmaceutical Investment Development Co.
, Ltd.
for the development of the pharmaceutical retail enterprise Baiyuantang.
The market share of Lingrui's five major products in physical pharmacies in key cities in recent years
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Lingrui Pharmaceutical's five products, including Tongluo Qutong Cream, Zhuanggu Shexiang Pain Relief Cream, and Joint Pain Relief Cream, are all in the TOP20 brands.
Among them, Tongluo Qutong Ointment is an exclusive product, which has the function of promoting blood circulation and dredging collaterals, dispelling cold and dehumidifying, reducing swelling and pain.
It is mainly used for waist and knee osteoarthritis, blood stasis and stagnation.
According to data from Menet.
com, Tongluo Qutong Ointment has grown rapidly in physical pharmacies in key cities in recent years , with sales exceeding 100 million yuan in 2019, and it is expected to reach a new high in 2020.
Among them, Tongluo Qutong Ointment is an exclusive product, which has the function of promoting blood circulation and dredging collaterals, dispelling cold and dehumidifying, reducing swelling and pain.
It is mainly used for waist and knee osteoarthritis, blood stasis and stagnation.
According to data from Menet.
com, Tongluo Qutong Ointment has grown rapidly in physical pharmacies in key cities in recent years , with sales exceeding 100 million yuan in 2019, and it is expected to reach a new high in 2020.
According to the data, Lingrui Pharmaceutical's products focus on orthopedics and cardiovascular and cerebrovascular fields.
Currently, its main products are Tongluo Qutong ointment, Huoxue Xiaotong tincture, Zhuanggu Musk pain relief ointment, Shufu plaster and other external preparations, and Peiyuan Tongnao Capsules, Shenqi Jiangtang Capsules, Danyu Tongmai Granules and other oral preparations.
It is worth mentioning that the company has a leading position in the production and sales of orthopedic plaster products, and its plaster revenue has exceeded 1 billion yuan in the first three quarters of 2020.
In January this year, Lingrui Pharmaceutical received the "High-tech Enterprise Certificate" jointly issued by Henan Provincial Department of Science and Technology, Henan Provincial Department of Finance, and Henan Provincial Taxation Bureau of the State Administration of Taxation.
Currently, its main products are Tongluo Qutong ointment, Huoxue Xiaotong tincture, Zhuanggu Musk pain relief ointment, Shufu plaster and other external preparations, and Peiyuan Tongnao Capsules, Shenqi Jiangtang Capsules, Danyu Tongmai Granules and other oral preparations.
It is worth mentioning that the company has a leading position in the production and sales of orthopedic plaster products, and its plaster revenue has exceeded 1 billion yuan in the first three quarters of 2020.
In January this year, Lingrui Pharmaceutical received the "High-tech Enterprise Certificate" jointly issued by Henan Provincial Department of Science and Technology, Henan Provincial Department of Finance, and Henan Provincial Taxation Bureau of the State Administration of Taxation.
Shennong Pain Relief Ointment broke through the 100 million yuan mark, and this pharmaceutical company bucked the trend and grew by nearly 30%
Market share of Shennong Pain Relief Ointment in physical pharmacies in key cities in recent years
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Shennong Analgesic Ointment has the function of promoting blood circulation, removing blood stasis, reducing swelling and pain, and is used for bruises, rheumatism and joint pain, back pain.
According to data from Meinenet, the sales of Shennong Analgesic Ointment in physical pharmacies in key cities have increased steadily in recent years, and it is expected to exceed the 100 million yuan mark in 2020.
At present, the manufacturers with Shennong Analgesic Ointment production approval include Huangshi Yanwu Pharmaceutical, Zhanjiang Jimin Pharmaceutical and Lingrui Pharmaceutical.
Among them, Huangshi Yanwu Pharmaceutical has the largest market share, accounting for more than 60%; Zhanjiang Jimin Pharmaceutical Sales grew rapidly, approaching 30%.
According to data from Meinenet, the sales of Shennong Analgesic Ointment in physical pharmacies in key cities have increased steadily in recent years, and it is expected to exceed the 100 million yuan mark in 2020.
At present, the manufacturers with Shennong Analgesic Ointment production approval include Huangshi Yanwu Pharmaceutical, Zhanjiang Jimin Pharmaceutical and Lingrui Pharmaceutical.
Among them, Huangshi Yanwu Pharmaceutical has the largest market share, accounting for more than 60%; Zhanjiang Jimin Pharmaceutical Sales grew rapidly, approaching 30%.
Source: Mi Nei.
com database, company announcement
com database, company announcement
Note: The terminal competition pattern of physical pharmacies in key cities of Minai.
com is based on the sales data of all physical pharmacies in 22 key cities, including Beijing, Shanghai, Guangzhou, and Shenzhen, and is a sample city drug database that continuously monitors all categories.
The above sales are calculated based on the average retail price of the product at the terminal.
com is based on the sales data of all physical pharmacies in 22 key cities, including Beijing, Shanghai, Guangzhou, and Shenzhen, and is a sample city drug database that continuously monitors all categories.
The above sales are calculated based on the average retail price of the product at the terminal.
Medical News, March 29, Chinese patent medicinal plaster is a traditional method of external administration in my country, and it has always been favored by the public, and pharmacies are the main channel for its sales.
According to data from Menet.
com, the market for proprietary Chinese medicine plasters in physical pharmacies in key cities has grown steadily in recent years.
In 2020, affected by the epidemic, sales are expected to decline year-on-year.
From the perspective of urban structure, Shenzhen, Shanghai, and Guangzhou rank among the top three in terms of sales.
The total market share of TOP20 products exceeds 80%.
Among them, 11 are exclusive products, involving Tibet Qizheng Tibetan Medicine, Yunnan Baiyao Group Wuxi Pharmaceutical, Henan Lingrui Pharmaceutical, Yabao Pharmaceutical Group, Jiangsu Kangyuan Sunshine Pharmaceutical Industry and other enterprises.
In terms of brand TOP20, Tibet Qizheng Tibetan Medicine's Xiaotong Plaster, Yunnan Baiyao Wuxi Pharmaceutical's Yunnan Baiyao Gao, Anke Yuliangqing Pharmaceutical's Huoxue Zhitong Gao ranked in the top three; in terms of the number of brands, Henan Lingrui The number of pharmaceuticals is the most, there are five.
According to data from Menet.
com, the market for proprietary Chinese medicine plasters in physical pharmacies in key cities has grown steadily in recent years.
In 2020, affected by the epidemic, sales are expected to decline year-on-year.
From the perspective of urban structure, Shenzhen, Shanghai, and Guangzhou rank among the top three in terms of sales.
The total market share of TOP20 products exceeds 80%.
Among them, 11 are exclusive products, involving Tibet Qizheng Tibetan Medicine, Yunnan Baiyao Group Wuxi Pharmaceutical, Henan Lingrui Pharmaceutical, Yabao Pharmaceutical Group, Jiangsu Kangyuan Sunshine Pharmaceutical Industry and other enterprises.
In terms of brand TOP20, Tibet Qizheng Tibetan Medicine's Xiaotong Plaster, Yunnan Baiyao Wuxi Pharmaceutical's Yunnan Baiyao Gao, Anke Yuliangqing Pharmaceutical's Huoxue Zhitong Gao ranked in the top three; in terms of the number of brands, Henan Lingrui The number of pharmaceuticals is the most, there are five.
Chinese patent medicinal plasters "Shenzhen, Shanghai and Guangzhou" are selling well! Qizheng, Lingrui.
.
.
11 exclusive products "Baping"
.
.
11 exclusive products "Baping"
2020E city layout of proprietary Chinese medicine plasters in physical pharmacies in key cities (unit: ten thousand yuan)
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
According to data from Menet.
com, the market for proprietary Chinese medicine plasters in physical pharmacies in key cities has grown steadily in recent years.
In 2020, affected by the epidemic, sales are expected to decline year-on-year.
From the perspective of the urban structure, Shenzhen, Shanghai, and Guangzhou rank among the top three in terms of sales.
Among them, Shenzhen is the only city with a sales volume of over 300 million yuan, followed by Shanghai.
In addition, Guangzhou, Tianjin, Hangzhou and other cities have sales of more than 100 million yuan.
com, the market for proprietary Chinese medicine plasters in physical pharmacies in key cities has grown steadily in recent years.
In 2020, affected by the epidemic, sales are expected to decline year-on-year.
From the perspective of the urban structure, Shenzhen, Shanghai, and Guangzhou rank among the top three in terms of sales.
Among them, Shenzhen is the only city with a sales volume of over 300 million yuan, followed by Shanghai.
In addition, Guangzhou, Tianjin, Hangzhou and other cities have sales of more than 100 million yuan.
2020E Key City Entity Pharmacy TCM Plaster Products TOP20
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Note: * is an exclusive product
The total market share of TOP20 products accounted for more than 80%, and the market concentration was high.
There were 9 products with sales exceeding 100 million yuan.
The number of orthopedic analgesics was the largest, with 10, followed by six traumatic injuries.
Among them, Xiaotong Plaster is firmly in the "sales crown" throne, with a market share of more than 15%; Yunnan Baiyao Ointment ranks second with 10.
23%.
In addition, among the TOP20 products, there are 11 exclusive products, involving Tibet Qizheng Tibetan Medicine, Yunnan Baiyao Group Wuxi Pharmaceutical, Henan Lingrui Pharmaceutical, Yabao Pharmaceutical Group, Sinopharm Dezhong (Foshan) Pharmaceutical, Jiangsu Kangyuan Sunshine Pharmaceutical and other companies.
There were 9 products with sales exceeding 100 million yuan.
The number of orthopedic analgesics was the largest, with 10, followed by six traumatic injuries.
Among them, Xiaotong Plaster is firmly in the "sales crown" throne, with a market share of more than 15%; Yunnan Baiyao Ointment ranks second with 10.
23%.
In addition, among the TOP20 products, there are 11 exclusive products, involving Tibet Qizheng Tibetan Medicine, Yunnan Baiyao Group Wuxi Pharmaceutical, Henan Lingrui Pharmaceutical, Yabao Pharmaceutical Group, Sinopharm Dezhong (Foshan) Pharmaceutical, Jiangsu Kangyuan Sunshine Pharmaceutical and other companies.
2020E Key City Entity Pharmacy TCM Plaster Brand TOP20
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
In terms of brand TOP20, Tibet Qizheng Tibetan Medicine's Xiaotong Plaster, Yunnan Baiyao Wuxi Pharmaceutical's Yunnan Baiyao Cream, Anke Yuliangqing Pharmaceutical's Huoxuezhitong Ointment ranked in the top three, Henan Lingrui Pharmaceutical's Tongluo Qupain Five products including Zhuanggushexiang Pain Relief Cream and Joint Pain Relief Cream are among the TOP20 brands.
Xiaotong Plaster is firmly in the top of the market, and Lingrui's five major brands are eye-catching
Market share of Xiaotong plaster in physical pharmacies in key cities in recent years
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Xiaotong Plaster is used for acute and chronic sprains, bruises and bruises, bone hyperplasia, rheumatism and rheumatoid pain, frozen shoulder, etc.
It is the exclusive product of Tibet Qizheng Tibetan Medicine.
According to data from Meinnet.
com, the sales of physical medicine Xiaotong plasters in key cities have exceeded 300 million yuan in recent years, ranking first in the market share of proprietary Chinese medicine plasters for many years.
At the end of December 2020, Qizheng Tibetan Medicine issued an announcement stating that its two exclusive products, Honghua Ruyi Pills and Ruyi Zhenbao Tablets, were included in the "National Medical Insurance Catalog (2020)" for the first time, which will expand the market network and upgrade the two products.
The sales scale plays a positive role in promoting and has a positive impact on the company's long-term business development.
In addition, the company has 17 varieties including Xiaotong Plaster, Baimai Ointment, Qingpeng Ointment, Renqing Mangjue Capsule, etc.
, which have been included in the "National Medical Insurance Catalogue (2020)".
It is the exclusive product of Tibet Qizheng Tibetan Medicine.
According to data from Meinnet.
com, the sales of physical medicine Xiaotong plasters in key cities have exceeded 300 million yuan in recent years, ranking first in the market share of proprietary Chinese medicine plasters for many years.
At the end of December 2020, Qizheng Tibetan Medicine issued an announcement stating that its two exclusive products, Honghua Ruyi Pills and Ruyi Zhenbao Tablets, were included in the "National Medical Insurance Catalog (2020)" for the first time, which will expand the market network and upgrade the two products.
The sales scale plays a positive role in promoting and has a positive impact on the company's long-term business development.
In addition, the company has 17 varieties including Xiaotong Plaster, Baimai Ointment, Qingpeng Ointment, Renqing Mangjue Capsule, etc.
, which have been included in the "National Medical Insurance Catalogue (2020)".
In February of this year, Qizheng Tibetan Medicine disclosed its 2020 performance report, with revenue of 1.
476 billion yuan, an increase of 5.
24% year-on-year, of which the pharmaceutical business increased by 4.
55% year-on-year; net profit was 406 million yuan, an increase of 11.
39% year-on-year, with steady growth in performance.
Recently, Qizheng Tibetan Medicine announced its participation in the establishment of an equity investment fund.
The company signed an agreement with Guangyao Jinshen and Guangyao Baiyunshan to jointly establish Guangzhou Guangyao Jinzang Equity Investment Partnership (Limited Partnership) with a total scale of 115 million Yuan, the company as a limited partner subscribed to contribute 67.
85 million yuan (accounting for 59%).
The fund specifically invested in Guangzhou Baiyunshan Yixintang Pharmaceutical Investment Development Co.
, Ltd.
for the development of the pharmaceutical retail enterprise Baiyuantang.
476 billion yuan, an increase of 5.
24% year-on-year, of which the pharmaceutical business increased by 4.
55% year-on-year; net profit was 406 million yuan, an increase of 11.
39% year-on-year, with steady growth in performance.
Recently, Qizheng Tibetan Medicine announced its participation in the establishment of an equity investment fund.
The company signed an agreement with Guangyao Jinshen and Guangyao Baiyunshan to jointly establish Guangzhou Guangyao Jinzang Equity Investment Partnership (Limited Partnership) with a total scale of 115 million Yuan, the company as a limited partner subscribed to contribute 67.
85 million yuan (accounting for 59%).
The fund specifically invested in Guangzhou Baiyunshan Yixintang Pharmaceutical Investment Development Co.
, Ltd.
for the development of the pharmaceutical retail enterprise Baiyuantang.
The market share of Lingrui's five major products in physical pharmacies in key cities in recent years
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Lingrui Pharmaceutical's five products, including Tongluo Qutong Cream, Zhuanggu Shexiang Pain Relief Cream, and Joint Pain Relief Cream, are all in the TOP20 brands.
Among them, Tongluo Qutong Ointment is an exclusive product, which has the function of promoting blood circulation and dredging collaterals, dispelling cold and dehumidifying, reducing swelling and pain.
It is mainly used for waist and knee osteoarthritis, blood stasis and stagnation.
According to data from Menet.
com, Tongluo Qutong Ointment has grown rapidly in physical pharmacies in key cities in recent years , with sales exceeding 100 million yuan in 2019, and it is expected to reach a new high in 2020.
Among them, Tongluo Qutong Ointment is an exclusive product, which has the function of promoting blood circulation and dredging collaterals, dispelling cold and dehumidifying, reducing swelling and pain.
It is mainly used for waist and knee osteoarthritis, blood stasis and stagnation.
According to data from Menet.
com, Tongluo Qutong Ointment has grown rapidly in physical pharmacies in key cities in recent years , with sales exceeding 100 million yuan in 2019, and it is expected to reach a new high in 2020.
According to the data, Lingrui Pharmaceutical's products focus on orthopedics and cardiovascular and cerebrovascular fields.
Currently, its main products are Tongluo Qutong ointment, Huoxue Xiaotong tincture, Zhuanggu Musk pain relief ointment, Shufu plaster and other external preparations, and Peiyuan Tongnao Capsules, Shenqi Jiangtang Capsules, Danyu Tongmai Granules and other oral preparations.
It is worth mentioning that the company has a leading position in the production and sales of orthopedic plaster products, and its plaster revenue has exceeded 1 billion yuan in the first three quarters of 2020.
In January this year, Lingrui Pharmaceutical received the "High-tech Enterprise Certificate" jointly issued by Henan Provincial Department of Science and Technology, Henan Provincial Department of Finance, and Henan Provincial Taxation Bureau of the State Administration of Taxation.
Currently, its main products are Tongluo Qutong ointment, Huoxue Xiaotong tincture, Zhuanggu Musk pain relief ointment, Shufu plaster and other external preparations, and Peiyuan Tongnao Capsules, Shenqi Jiangtang Capsules, Danyu Tongmai Granules and other oral preparations.
It is worth mentioning that the company has a leading position in the production and sales of orthopedic plaster products, and its plaster revenue has exceeded 1 billion yuan in the first three quarters of 2020.
In January this year, Lingrui Pharmaceutical received the "High-tech Enterprise Certificate" jointly issued by Henan Provincial Department of Science and Technology, Henan Provincial Department of Finance, and Henan Provincial Taxation Bureau of the State Administration of Taxation.
Shennong Pain Relief Ointment broke through the 100 million yuan mark, and this pharmaceutical company bucked the trend and grew by nearly 30%
Market share of Shennong Pain Relief Ointment in physical pharmacies in key cities in recent years
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Shennong Analgesic Ointment has the function of promoting blood circulation, removing blood stasis, reducing swelling and pain, and is used for bruises, rheumatism and joint pain, back pain.
According to data from Meinenet, the sales of Shennong Analgesic Ointment in physical pharmacies in key cities have increased steadily in recent years, and it is expected to exceed the 100 million yuan mark in 2020.
At present, the manufacturers with Shennong Analgesic Ointment production approval include Huangshi Yanwu Pharmaceutical, Zhanjiang Jimin Pharmaceutical and Lingrui Pharmaceutical.
Among them, Huangshi Yanwu Pharmaceutical has the largest market share, accounting for more than 60%; Zhanjiang Jimin Pharmaceutical Sales grew rapidly, approaching 30%.
According to data from Meinenet, the sales of Shennong Analgesic Ointment in physical pharmacies in key cities have increased steadily in recent years, and it is expected to exceed the 100 million yuan mark in 2020.
At present, the manufacturers with Shennong Analgesic Ointment production approval include Huangshi Yanwu Pharmaceutical, Zhanjiang Jimin Pharmaceutical and Lingrui Pharmaceutical.
Among them, Huangshi Yanwu Pharmaceutical has the largest market share, accounting for more than 60%; Zhanjiang Jimin Pharmaceutical Sales grew rapidly, approaching 30%.
Source: Mi Nei.
com database, company announcement
com database, company announcement
Note: The terminal competition pattern of physical pharmacies in key cities of Minai.
com is based on the sales data of all physical pharmacies in 22 key cities, including Beijing, Shanghai, Guangzhou, and Shenzhen, and is a sample city drug database that continuously monitors all categories.
The above sales are calculated based on the average retail price of the product at the terminal.
com is based on the sales data of all physical pharmacies in 22 key cities, including Beijing, Shanghai, Guangzhou, and Shenzhen, and is a sample city drug database that continuously monitors all categories.
The above sales are calculated based on the average retail price of the product at the terminal.
Medical News, March 29, Chinese patent medicinal plaster is a traditional method of external administration in my country, and it has always been favored by the public, and pharmacies are the main channel for its sales.
According to data from Menet.
com, the market for proprietary Chinese medicine plasters in physical pharmacies in key cities has grown steadily in recent years.
In 2020, affected by the epidemic, sales are expected to decline year-on-year.
From the perspective of urban structure, Shenzhen, Shanghai, and Guangzhou rank among the top three in terms of sales.
The total market share of TOP20 products exceeds 80%.
Among them, 11 are exclusive products, involving Tibet Qizheng Tibetan Medicine, Yunnan Baiyao Group Wuxi Pharmaceutical, Henan Lingrui Pharmaceutical, Yabao Pharmaceutical Group, Jiangsu Kangyuan Sunshine Pharmaceutical Industry and other enterprises.
In terms of brand TOP20, Tibet Qizheng Tibetan Medicine's Xiaotong Plaster, Yunnan Baiyao Wuxi Pharmaceutical's Yunnan Baiyao Gao, Anke Yuliangqing Pharmaceutical's Huoxue Zhitong Gao ranked in the top three; in terms of the number of brands, Henan Lingrui The number of pharmaceuticals is the most, there are five.
According to data from Menet.
com, the market for proprietary Chinese medicine plasters in physical pharmacies in key cities has grown steadily in recent years.
In 2020, affected by the epidemic, sales are expected to decline year-on-year.
From the perspective of urban structure, Shenzhen, Shanghai, and Guangzhou rank among the top three in terms of sales.
The total market share of TOP20 products exceeds 80%.
Among them, 11 are exclusive products, involving Tibet Qizheng Tibetan Medicine, Yunnan Baiyao Group Wuxi Pharmaceutical, Henan Lingrui Pharmaceutical, Yabao Pharmaceutical Group, Jiangsu Kangyuan Sunshine Pharmaceutical Industry and other enterprises.
In terms of brand TOP20, Tibet Qizheng Tibetan Medicine's Xiaotong Plaster, Yunnan Baiyao Wuxi Pharmaceutical's Yunnan Baiyao Gao, Anke Yuliangqing Pharmaceutical's Huoxue Zhitong Gao ranked in the top three; in terms of the number of brands, Henan Lingrui The number of pharmaceuticals is the most, there are five.
Chinese patent medicinal plasters "Shenzhen, Shanghai and Guangzhou" are selling well! Qizheng, Lingrui.
.
.
11 exclusive products "Baping"
Chinese patent medicinal plasters "Shenzhen, Shanghai and Guangzhou" are selling well! Qizheng, Lingrui. .
.
11 exclusive products "Baping"
.
.
11 exclusive products "Baping"
2020E city layout of proprietary Chinese medicine plasters in physical pharmacies in key cities (unit: ten thousand yuan)
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
According to data from Menet.
com, the market for proprietary Chinese medicine plasters in physical pharmacies in key cities has grown steadily in recent years.
In 2020, affected by the epidemic, sales are expected to decline year-on-year.
From the perspective of the urban structure, Shenzhen, Shanghai, and Guangzhou rank among the top three in terms of sales.
Among them, Shenzhen is the only city with a sales volume of over 300 million yuan, followed by Shanghai.
In addition, Guangzhou, Tianjin, Hangzhou and other cities have sales of more than 100 million yuan.
com, the market for proprietary Chinese medicine plasters in physical pharmacies in key cities has grown steadily in recent years.
In 2020, affected by the epidemic, sales are expected to decline year-on-year.
From the perspective of the urban structure, Shenzhen, Shanghai, and Guangzhou rank among the top three in terms of sales.
Among them, Shenzhen is the only city with a sales volume of over 300 million yuan, followed by Shanghai.
In addition, Guangzhou, Tianjin, Hangzhou and other cities have sales of more than 100 million yuan.
2020E Key City Entity Pharmacy TCM Plaster Products TOP20
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Note: * is an exclusive product
The total market share of TOP20 products accounted for more than 80%, and the market concentration was high.
There were 9 products with sales exceeding 100 million yuan.
The number of orthopedic analgesics was the largest, with 10, followed by six traumatic injuries.
Among them, Xiaotong Plaster is firmly in the "sales crown" throne, with a market share of more than 15%; Yunnan Baiyao Ointment ranks second with 10.
23%.
In addition, among the TOP20 products, there are 11 exclusive products, involving Tibet Qizheng Tibetan Medicine, Yunnan Baiyao Group Wuxi Pharmaceutical, Henan Lingrui Pharmaceutical, Yabao Pharmaceutical Group, Sinopharm Dezhong (Foshan) Pharmaceutical, Jiangsu Kangyuan Sunshine Pharmaceutical and other companies.
There were 9 products with sales exceeding 100 million yuan.
The number of orthopedic analgesics was the largest, with 10, followed by six traumatic injuries.
Among them, Xiaotong Plaster is firmly in the "sales crown" throne, with a market share of more than 15%; Yunnan Baiyao Ointment ranks second with 10.
23%.
In addition, among the TOP20 products, there are 11 exclusive products, involving Tibet Qizheng Tibetan Medicine, Yunnan Baiyao Group Wuxi Pharmaceutical, Henan Lingrui Pharmaceutical, Yabao Pharmaceutical Group, Sinopharm Dezhong (Foshan) Pharmaceutical, Jiangsu Kangyuan Sunshine Pharmaceutical and other companies.
2020E Key City Entity Pharmacy TCM Plaster Brand TOP20
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
In terms of brand TOP20, Tibet Qizheng Tibetan Medicine's Xiaotong Plaster, Yunnan Baiyao Wuxi Pharmaceutical's Yunnan Baiyao Cream, Anke Yuliangqing Pharmaceutical's Huoxuezhitong Ointment ranked in the top three, Henan Lingrui Pharmaceutical's Tongluo Qupain Five products including Zhuanggushexiang Pain Relief Cream and Joint Pain Relief Cream are among the TOP20 brands.
Xiaotong Plaster is firmly in the top of the market, and Lingrui's five major brands are eye-catching
Xiaotong Plaster is firmly in the top of the market, and Lingrui's five major brands are eye-catching Market share of Xiaotong plaster in physical pharmacies in key cities in recent years
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Xiaotong Plaster is used for acute and chronic sprains, bruises and bruises, bone hyperplasia, rheumatism and rheumatoid pain, frozen shoulder, etc.
It is the exclusive product of Tibet Qizheng Tibetan Medicine.
According to data from Meinnet.
com, the sales of physical medicine Xiaotong plasters in key cities have exceeded 300 million yuan in recent years, ranking first in the market share of proprietary Chinese medicine plasters for many years.
At the end of December 2020, Qizheng Tibetan Medicine issued an announcement stating that its two exclusive products, Honghua Ruyi Pills and Ruyi Zhenbao Tablets, were included in the "National Medical Insurance Catalog (2020)" for the first time, which will expand the market network and upgrade the two products.
The sales scale plays a positive role in promoting and has a positive impact on the company's long-term business development.
In addition, the company has 17 varieties including Xiaotong Plaster, Baimai Ointment, Qingpeng Ointment, Renqing Mangjue Capsule, etc.
, which have been included in the "National Medical Insurance Catalogue (2020)".
It is the exclusive product of Tibet Qizheng Tibetan Medicine.
According to data from Meinnet.
com, the sales of physical medicine Xiaotong plasters in key cities have exceeded 300 million yuan in recent years, ranking first in the market share of proprietary Chinese medicine plasters for many years.
At the end of December 2020, Qizheng Tibetan Medicine issued an announcement stating that its two exclusive products, Honghua Ruyi Pills and Ruyi Zhenbao Tablets, were included in the "National Medical Insurance Catalog (2020)" for the first time, which will expand the market network and upgrade the two products.
The sales scale plays a positive role in promoting and has a positive impact on the company's long-term business development.
In addition, the company has 17 varieties including Xiaotong Plaster, Baimai Ointment, Qingpeng Ointment, Renqing Mangjue Capsule, etc.
, which have been included in the "National Medical Insurance Catalogue (2020)".
In February of this year, Qizheng Tibetan Medicine disclosed its 2020 performance report, with revenue of 1.
476 billion yuan, an increase of 5.
24% year-on-year, of which the pharmaceutical business increased by 4.
55% year-on-year; net profit was 406 million yuan, an increase of 11.
39% year-on-year, with steady growth in performance.
Recently, Qizheng Tibetan Medicine announced its participation in the establishment of an equity investment fund.
The company signed an agreement with Guangyao Jinshen and Guangyao Baiyunshan to jointly establish Guangzhou Guangyao Jinzang Equity Investment Partnership (Limited Partnership) with a total scale of 115 million Yuan, the company as a limited partner subscribed to contribute 67.
85 million yuan (accounting for 59%).
The fund specifically invested in Guangzhou Baiyunshan Yixintang Pharmaceutical Investment Development Co.
, Ltd.
for the development of the pharmaceutical retail enterprise Baiyuantang.
Drugs Drugs Drugs pharmaceutical medicine pharmaceutical companies business enterprises476 billion yuan, an increase of 5.
24% year-on-year, of which the pharmaceutical business increased by 4.
55% year-on-year; net profit was 406 million yuan, an increase of 11.
39% year-on-year, with steady growth in performance.
Recently, Qizheng Tibetan Medicine announced its participation in the establishment of an equity investment fund.
The company signed an agreement with Guangyao Jinshen and Guangyao Baiyunshan to jointly establish Guangzhou Guangyao Jinzang Equity Investment Partnership (Limited Partnership) with a total scale of 115 million Yuan, the company as a limited partner subscribed to contribute 67.
85 million yuan (accounting for 59%).
The fund specifically invested in Guangzhou Baiyunshan Yixintang Pharmaceutical Investment Development Co.
, Ltd.
for the development of the pharmaceutical retail enterprise Baiyuantang.
The market share of Lingrui's five major products in physical pharmacies in key cities in recent years
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Lingrui Pharmaceutical's five products, including Tongluo Qutong Cream, Zhuanggu Shexiang Pain Relief Cream, and Joint Pain Relief Cream, are all in the TOP20 brands.
Among them, Tongluo Qutong Ointment is an exclusive product, which has the function of promoting blood circulation and dredging collaterals, dispelling cold and dehumidifying, reducing swelling and pain.
It is mainly used for waist and knee osteoarthritis, blood stasis and stagnation.
According to data from Menet.
com, Tongluo Qutong Ointment has grown rapidly in physical pharmacies in key cities in recent years , with sales exceeding 100 million yuan in 2019, and it is expected to reach a new high in 2020.
Pharmacy pharmacy pharmacyAmong them, Tongluo Qutong Ointment is an exclusive product, which has the function of promoting blood circulation and dredging collaterals, dispelling cold and dehumidifying, reducing swelling and pain.
It is mainly used for waist and knee osteoarthritis, blood stasis and stagnation.
According to data from Menet.
com, Tongluo Qutong Ointment has grown rapidly in physical pharmacies in key cities in recent years , with sales exceeding 100 million yuan in 2019, and it is expected to reach a new high in 2020.
According to the data, Lingrui Pharmaceutical's products focus on orthopedics and cardiovascular and cerebrovascular fields.
Currently, its main products are Tongluo Qutong ointment, Huoxue Xiaotong tincture, Zhuanggu Musk pain relief ointment, Shufu plaster and other external preparations, and Peiyuan Tongnao Capsules, Shenqi Jiangtang Capsules, Danyu Tongmai Granules and other oral preparations.
It is worth mentioning that the company has a leading position in the production and sales of orthopedic plaster products, and its plaster revenue has exceeded 1 billion yuan in the first three quarters of 2020.
In January this year, Lingrui Pharmaceutical received the "High-tech Enterprise Certificate" jointly issued by Henan Provincial Department of Science and Technology, Henan Provincial Department of Finance, and Henan Provincial Taxation Bureau of the State Administration of Taxation.
Currently, its main products are Tongluo Qutong ointment, Huoxue Xiaotong tincture, Zhuanggu Musk pain relief ointment, Shufu plaster and other external preparations, and Peiyuan Tongnao Capsules, Shenqi Jiangtang Capsules, Danyu Tongmai Granules and other oral preparations.
It is worth mentioning that the company has a leading position in the production and sales of orthopedic plaster products, and its plaster revenue has exceeded 1 billion yuan in the first three quarters of 2020.
In January this year, Lingrui Pharmaceutical received the "High-tech Enterprise Certificate" jointly issued by Henan Provincial Department of Science and Technology, Henan Provincial Department of Finance, and Henan Provincial Taxation Bureau of the State Administration of Taxation.
Shennong Pain Relief Ointment broke through the 100 million yuan mark, and this pharmaceutical company bucked the trend and grew by nearly 30%
Shennong Pain Relief Ointment broke through the 100 million yuan mark, and this pharmaceutical company bucked the trend and grew by nearly 30% Market share of Shennong Pain Relief Ointment in physical pharmacies in key cities in recent years
Source: Mi Nei.
com's terminal competition pattern of physical pharmacies in key cities
com's terminal competition pattern of physical pharmacies in key cities
Shennong Analgesic Ointment has the function of promoting blood circulation, removing blood stasis, reducing swelling and pain, and is used for bruises, rheumatism and joint pain, back pain.
According to data from Meinenet, the sales of Shennong Analgesic Ointment in physical pharmacies in key cities have increased steadily in recent years, and it is expected to exceed the 100 million yuan mark in 2020.
At present, the manufacturers with Shennong Analgesic Ointment production approval include Huangshi Yanwu Pharmaceutical, Zhanjiang Jimin Pharmaceutical and Lingrui Pharmaceutical.
Among them, Huangshi Yanwu Pharmaceutical has the largest market share, accounting for more than 60%; Zhanjiang Jimin Pharmaceutical Sales grew rapidly, approaching 30%.
According to data from Meinenet, the sales of Shennong Analgesic Ointment in physical pharmacies in key cities have increased steadily in recent years, and it is expected to exceed the 100 million yuan mark in 2020.
At present, the manufacturers with Shennong Analgesic Ointment production approval include Huangshi Yanwu Pharmaceutical, Zhanjiang Jimin Pharmaceutical and Lingrui Pharmaceutical.
Among them, Huangshi Yanwu Pharmaceutical has the largest market share, accounting for more than 60%; Zhanjiang Jimin Pharmaceutical Sales grew rapidly, approaching 30%.
Source: Mi Nei.
com database, company announcement
com database, company announcement
Note: The terminal competition pattern of physical pharmacies in key cities of Minai.
com is based on the sales data of all physical pharmacies in 22 key cities, including Beijing, Shanghai, Guangzhou, and Shenzhen, and is a sample city drug database that continuously monitors all categories.
The above sales are calculated based on the average retail price of the product at the terminal.
com is based on the sales data of all physical pharmacies in 22 key cities, including Beijing, Shanghai, Guangzhou, and Shenzhen, and is a sample city drug database that continuously monitors all categories.
The above sales are calculated based on the average retail price of the product at the terminal.
